Regulation of P-glycoprotein I and 2 gene expression and protein activity in two MCF-7/Dox cell line subclones
1996

Regulation of P-glycoprotein in MCF-7/Dox Cell Lines

publication Evidence: moderate

Author Information

Author(s): R Davies, J Budworth, J Riley, R Snowden, A Gescher, TW Gant

Primary Institution: MRC Toxicology Unit

Hypothesis

How is P-glycoprotein expression and activity regulated in doxorubicin-resistant MCF-7 cell lines?

Conclusion

The study found that two subclones of MCF-7/Dox cells exhibit different levels of P-glycoprotein expression and drug resistance mechanisms.

Supporting Evidence

  • LP-gp and HP-gp cells showed different levels of P-glycoprotein expression.
  • HP-gp cells had a 10-fold higher level of P-glycoprotein than LP-gp cells.
  • MDR1 mRNA levels were significantly higher in both LP-gp and HP-gp cells compared to wild-type.
  • PKC isozyme levels were analyzed to understand their role in P-glycoprotein regulation.

Takeaway

Researchers looked at two types of cancer cells that resist a drug and found they behave differently based on how much of a certain protein they have.

Methodology

The study used fluorescence-activated cell sorting (FACS) to separate cell populations and analyzed gene expression using RT-PCR.

Limitations

The study primarily focused on in vitro models, which may not fully represent in vivo conditions.

Statistical Information

P-Value

p<0.05

Statistical Significance

p<0.05

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication